• Capillus Mobile LLLT Device for Hair Regrowth Receives FDA Clearance

    Capillus, LLC announces that the Capillus272™ low level laser therapy (LLLT) device has been cleared by the Food and Drug Administration (FDA) for the treatment of androgenic alopecia. Miami-based medical device manufacturer, Capillus, LLC, announces that the Capillus272™ has received 510(k) clearance from the Food and Drug Administration. With no known side effects and the highest energy output of any home-use low level laser...
  • Clinical Trial Proves Efficacy of Laser Hair Restoration, Available at Hair Transplant Institute Miami

    A new clinical trial proves low-level laser therapy (LLLT) devices effective in treating male and female pattern hair loss. These devices are now available to South Florida residents at Hair Transplant Institute of Miami. For the first time, low-level laser therapy (LLLT) devices prove successful in stimulating new hair growth in men and women who suffer with androgenetic alopecia, or pattern hair loss. In...
« Previous 1 10 11 12